A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade Glioma

NCT01390948 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

High Grade Glioma

Interventions

DRUG: Bevacizumab
RADIATION: Radiotherapy
DRUG: Temozolomide (TMZ)

Sponsor

Hoffmann-La Roche